Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA

Journal:
Nature Biotechnology
Published:
DOI:
10.1038/s41587-021-00981-w
Affiliations:
16
Authors:
29
Institutions Authors Share
Stanford Medicine, United States of America (USA)
21.000000
21.000000
21.000000
0.72
Essen University Hospital, Germany
2.000000
0.07
NIH National Cancer Institute (NCI), United States of America (USA)
2.000000
0.07
The University of Texas MD Anderson Cancer Center, United States of America (USA)
1.000000
0.03
University of Eastern Piedmont "Amedeo Avogadro" (UNIPMN), Italy
1.000000
0.03
Institute of Oncology Research (IOR), IOSI, Switzerland
1.000000
0.03
Dijon University Hospital, France
0.500000
0.02
National Institute for Health and Medical Research (INSERM), France
0.500000
0.02